People | January 04, 2026
Zydus Group elevates Dr. Tushar Nahata to Vice President
His professional background also includes key experience at Matrix Labs and Sun Pharma
His professional background also includes key experience at Matrix Labs and Sun Pharma
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
The company’s consolidated revenue from operations rose to Rs. 361.13 crore in Q2 FY26 and Rs. 707.67 crore for the first half
The decision secures legal protection in China for semaglutide, the blockbuster drug underpinning Novo Nordisk’s diabetes and obesity treatments
The accelerated review covers WCK 5222 for multiple critical infections
Applications include detailed scientific rationale and supporting clinical evidence
Under his leadership, Chidamide became China’s first original small-molecule anti-tumor innovative drug and the country’s first pharmaceutical product globally licensed out
The plant is expected to enhance regional supply capabilities
The partnership also sets the stage for broader collaboration on rare disease treatments
CX-5461 is “the world's first and most advanced G-quadruplex (G4) stabilizer in development
Subscribe To Our Newsletter & Stay Updated
